Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients
Clinical Neuropsychopharmacology and Therapeutics · 2010
DOI: 10.5234/cnpt.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2010. Verfasst von Kazuo Mihara und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mihara, K., Nagai, G., Nakamura, A., Fukuji, Y., Suzuki, T., & Kondo, T. (2010). Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.1.1
Vancouver
Mihara K, Nagai G, Nakamura A, Fukuji Y, Suzuki T, Kondo T. Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients. Clinical Neuropsychopharmacology and Therapeutics. 2010. doi:10.5234/cnpt.1.1
BibTeX
@article{Mihara2010,
author = {Mihara, Kazuo and Nagai, Goyo and Nakamura, Akifumi and Fukuji, Yasuhide and Suzuki, Takeshi and Kondo, Tsuyoshi},
title = {Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients},
journal = {Clinical Neuropsychopharmacology and Therapeutics},
year = {2010},
doi = {10.5234/cnpt.1.1}
}
EUVIMED